Ja. Widness et al., DIRECT RELATIONSHIP OF FETAL CARBOXYHEMOGLOBIN WITH HEMOLYSIS IN ALLOIMMUNIZED PREGNANCIES, Pediatric research, 35(6), 1994, pp. 713-719
Because carbon monoxide (CO) is a byproduct of heme degradation and be
cause placental diffusing capacity of CO is limited, we hypothesized t
hat the concentration of CO transported in fetal blood as carboxyhemog
lobin (HbCO) would correlate with the severity of fetal hemolytic dise
ase. Fetal blood was obtained by cordocentesis and HbCO was measured b
y gas chromatography. The two primary study groups included control fe
tuses (n = 26) and fetuses of Coombs-positive mothers before in utero
transfusion (n = 15). Compared with controls, fetuses with hemolytic d
isease had higher HbCO levels (0.0111 +/- 0.0014 versus 0.0159 +/- 0.0
072 fraction of total Hb, mean +/- SD, p < 0.002). In contrast, HbCO l
evels in simultaneously sampled maternal blood samples were not differ
ent in the control and alloimmune groups [0.0110 +/- 0.0025 (n = 20) v
ersus 0.0115 +/- 0.0021 (n = 11)]. There was a significant inverse cor
relation observed between fetal HbCO and Hb concentrations in the grou
p with hemolytic disease (r = -0.73, p < 0.002) but not in controls. I
n fetuses with hemolytic disease, HbCO and bilirubin were highly corre
lated (r = 0.88, p < 0.0001). Data from four anemic fetuses who were C
oombs negative, three of whom had no evidence of hemolysis, indicated
normal HbCO and normal plasma bilirubin levels. A fourth fetus with an
emia had viral sepsis and elevated HbCO and plasma bilirubin levels. W
e conclude that elevated HbCO levels detected in fetuses of nonsmoking
mothers with erythrocyte alloimmunization are likely the result of ac
celerated hemolysis.